Siba Life Sciences Ltd is a New Delhi based molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing and marketing accurate yet easy-to-use molecular systems and tests. 

Founded in 2011, it has now become a significant player in the Indian pharmaceutical market, and is well known for marketing of anti-cancer drugs used in cancer chemotherapy as well as drugs used for supportive-care in oncology. The superior quality of anti-cancer products coupled with a strong product pipeline is the hallmark of the Siba Life Sciences. 

Apart from having an industry-leading oncology portfolio containing 10 products, Siba also houses broad range of products with 6 nutraceutical products, 4 Herbal products and many others in the pipeline. The importance of sustaining and spreading innovation throughout the world has never been greater. 

Our success is dependent on our ability to develop effective collaborative solutions from an “ecosystem of innovation” – bringing together patients, healthcare providers, industry, academia, payers and policymakers – to find solutions that can change the world for the better. By working together with national and international partners, we aim to change the course of human health so that diseases can be prevented, diagnosed early, successfully managed, and perhaps even cured. 

 Goal: 

To be the most respected, uniquely positioned leading biopharmaceutical company in India as well as abroad by providing good quality, affordable and innovative solutions in our products.

Our Team:

 Our team is configured to ensure continued growth and development. Each member of the executive team has been extensively vetted and involved in implementing successful business models in the various healthcare markets. Siba's board of directors and scientific advisory board are also a strategically aligned group of industry leaders.